Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab in COPD
NCT05320939Phase 2Unknown
- Sponsor
- Temple University
- Start
- Apr 2023
- Primary completion
- Apr 2024
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of mepolizumab in chronic obstructive pulmonary disease (COPD), sponsored by Temple University. Status: unknown.
02
Drugs
mepolizumab
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05320939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05320939.